- Staat
- SC
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 11.02.2022
- Impfdatum
- 15.12.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood glucose normal
Chronic sinusitis
Computerised tomogram head abnormal
Dizziness
Electroencephalogram normal
Fatigue
Headache
Seizure
Vomiting
Seizure like phenomena
Symptomtext
Patient had acute vomiting episode with dizziness in the bathroom of the office shortly after receiving the vaccine. Also, mom reports seizure like activity on the way home from the doctor's office that day. Also at 1700 that day he exhibited seizure like activity again.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- Patient seen at ER, per note had a head CT without contrast that showed no acute intracranial findings and chronic sinusitus. Also had a blood glucose done (results were 98). Seen by neurology on 12/22/21 with EEG with normal results.
- Aktuelle Erkrankungen
- Fever and URI (dx 11/22/2021)
- Vorgeschichte
- GERD, development delay, strabismus, allergic rhinitis
- Andere Medikamente
- none
- Allergien
- red dye, mint flavor, pineapple
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 21.04.2022
- Impfdatum
- 23.03.2022
- Beginn
- 25.03.2022
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Breast pain
Hypoaesthesia
Injection site erythema
Injection site induration
Injection site reaction
Injection site warmth
Pain
Paraesthesia
Symptomtext
Pt was seen on 3/23/22, she received vaccines given (IPV#4, Tdap#1, Varicella #2) on Rt arm. Pt c/o reddness, warm to touch, hard lump on back of rt arm. rt arm feels numb and fingers are tingly. Pt has not taking any medication for pain. Pt also feeling pain in rt breast area. 2:27PM reaction at site of HPV vaccine May be cellulitis ATB prescribed, advised to take 800mg ibuprofen Q8H with food until numbness and tingling ceases Risks and/or benefits and potential side effects of prescribed medication were reviewed with the parent/patient and all questions answered. Parent/patient verbalizes understanding, denies any barriers to adherence and agrees to call the clinic with any concerns. RTC in 5 days for f/u Report reaction if no improvement with antibiotics
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- Office Visit 4/21/22: #Vaccine reaction from 3/25/22 Resolved with antibiotics
- Aktuelle Erkrankungen
- Body Aches
- Vorgeschichte
- -
- Andere Medikamente
- Suatriptan Succinate 50mg, Omeprazole 20mg, Cetirizine 10mg, and Naproxen BID
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 25.05.2022
- Impfdatum
- 24.05.2022
- Beginn
- 24.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Pruritus
Pyrexia
Symptomtext
Vaccine was administered in the afternoon of 5/24/22. Pt states that she "had a fever and was itching all over" the night of 5/24/22. Pt denies rash/hives. Pt was advised to seek medical attention at local urgent care where she received a steroid injection and a prescription for prednisone.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Pink eye one week prior to vaccination
- Vorgeschichte
- Unknown
- Andere Medikamente
- None
- Allergien
- No allergies
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 28.01.2022
- Impfdatum
- 24.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash
Rash erythematous
Urticaria
Symptomtext
3 mins after vaccines were administered, patient developed bright red rash of both cheeks and chin. Also reticular rash on on chest with a few hives. Normal vital signs, happy and alert, smiling. No angioedema or respiratory symptoms. No vomiting or diarrhea. Given PO benadryl 6.25 mg x 1. Observed for 30 min. Rash receded. No further symptoms developed
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- COVID infection 2 weeks prior
- Vorgeschichte
- gross and oral motor delays- receiving PT, OT
- Andere Medikamente
- none
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 19.01.2022
- Impfdatum
- 17.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SYR / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Headache
Injection site discolouration
Injection site induration
Injection site inflammation
Injection site warmth
Malaise
Pain in extremity
Pyrexia
Symptomtext
Fever of 101f, tired, headache, tired aching legs, inflamed/hot/hard area in the left arm where the shot was administered (don?t know which shot was in which arm, tdap was given in one arm, varicella in the other) and discoloration of skin on arm. General unwell feeling. Missed school. Still have the effects two days later.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Multi vitamins only
- Allergien
- None
- Vorherige Impfungen
- 6 month old reaction to shot. Think it was flu shot or others given at 6 month routine doctors appointment
- Staat
- NH
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 20.12.2021
- Impfdatum
- 03.12.2021
- Beginn
- 12.12.2021
- Tage bis Beginn
- 9,0
- Dosis
- 1
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Nasal congestion
Papule
Pyrexia
Rash
Rash erythematous
Symptomtext
12/12/21 fever 101.5 with nasal congestion. 12/13/21 rash noted left lateral thigh and left mid-back. erythematous area with central papule, pinpoint vesicular site. 12/14/21 fever 101.7 with two additional similar sites right facial cheek and mid-forhead.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.04.2023
- Impfdatum
- 20.03.2023
- Beginn
- 20.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE or PQC reported; HCP reported VARIVAX was administered after the expiry date.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided. On 20-MAR-2023, the patient was administered with an expired dose of varicella virus vaccine live (Oka/Merck) (VARIVAX), dose of 0.5 mL, lot number: U008180, expiration date: 12-MAR-2023 (dose number, route of administration and anatomical location were not reported) for prophylaxis (expired product administered). The reporter confirmed that the varicella virus vaccine live (Oka/Merck) (VARIVAX) did not have a history of temperature excursions. No additional adverse event (AE) or product quality complaint (PQC) was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 30.03.2023
- Impfdatum
- 16.03.2023
- Beginn
- 16.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE.; VARIVAX was administered after expiration; This spontaneous report was received from a Medical Assistant and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported. On 16-MAR-2023, the patient was vaccinated with a dose of expired varicella virus vaccine live (oka/merck) (VARIVAX), 0.5 milliliter subcutaneous injection, 0.5 milliliter, lot #U008180, expiration date: 12-MAR-2023, administered for prophylaxis(route of administration was not provided) (expired product administered). This dose did not experience any temperature excursion. No additional adverse event.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 15.10.2022
- Impfdatum
- 03.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- ADHD
- Andere Medikamente
- -
- Allergien
- Bees
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- U
- Eingang
- 24.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; both VARIVAX and PROQUAD were involved in a temperature excursion on 9JUN2022.; This spontaneous report has been received from a certified medical assistant, regarding an unknown number of patients of unknown ages and genders. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant medications were unknown. On 09-JUN-2022, the following vaccines were involved in a temperature excursion: varicella virus vaccine live (oka/merck) (VARIVAX) as prophylaxis (lot number U008180 had been verified to be a valid number; expiration date reported and established as: 12-DEC-2023; (scheme, dosage and anatomical site of injection were not provided) and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA)(PROQUAD) as prophylaxis (lot number W007744 had been verified to be a valid number; expiration date reported and established as 04-SEP-2023. The vaccines were exposed to a temperature of 8.6 Fahrenheit degrees for a time frame of 13 minutes. No previous temperatures excursion were reported. On an unknown dates in 2022, the vaccines were administered to the patients (product storage error). No adverse events reported. This was a non-valid case due to lack of patient's identifiers.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 17.08.2022
- Impfdatum
- 17.11.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; VARIVAX was administered after a temperature excursion/Temperature: -13.6C; This spontaneous report was received from a healthcare business professional (HBP) referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 17-NOV-2021, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U008180 had verified to be a valid lot #, expiration date: 15-DEC-2023; strength, dose, anatomical location and route of administration were not provided) for prophylaxis. It was reported that the suspect vaccine was underwent temperature excursions of -13.6 degree Celsius (C) (the time frame was unknown) (product storage error). There were no previous temperature excursions. No additional adverse event (AE) was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 17.11.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse event; The product was administered to a patient after being improperly stored.; This spontaneous report has been received from a prescriber nurse concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, previous drug reactions or allergies and concomitant therapies were not provided. On an unknown date, the patient was vaccinated with one improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (dose, route of administration, vaccination scheme frequency and anatomical location were not reported; lot number U008180, that was verified to be a valid lot number with an expiration date reported and established as 12-MAR-2023) for prophylaxis (product storage error). The aforementioned administered dose underwent a temperature excursion as follows: 13 (units not provided) for 297 days. There was no previous temperature excursion. No other adverse event was reported (no adverse event). The report was considered to be non-valid due to lack of the patient's identifiers. Follow up information was received on 24-JUN-2022 from the prescriber nurse. The reporter informed that she is attempting to return forms, but her fax machine does not work and she was looking for an alternate route to send them. Additional information will be mailed. Follow up information was received from the prescriber nurse on 06-JUL-2022. The patient was a 14-years-old female. On 08-OCT-2021, the patient received dose of Hepatitis A Vaccine, Inactivated (VAQTA) intramuscular Injection, lot # T013205, expiration date established as 03-DEC-2021, administered intramuscularly in right deltoid; Hepatitis B vaccine manufacturer: GlaxoSmithKline, lot # 5295P, administered intramuscularly in right deltoid; meningococcal vaccine a/c/y/w conj (crm197) (MENVEO) manufacturer: GlaxoSmithKline, lot # AMVA438A, administered intramuscularly in left deltoid; and diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP), manufacturer: GlaxoSmithKline, lot # 57C57, administered intramuscularly in right deltoid; all for prophylaxis. On 17-NOV-2021 the patient was administered an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneously in right arm. The patient had no significant response to the vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- VAQTA; HEPATITIS B VACCINE; MENVEO; TDAP
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 21.04.2022
- Beginn
- 21.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Symptomtext
None. Patient reported no adverse events from vaccines given via intramuscular route rather than subcutaneous route. ** Please note: this report is due to administration error; to clarify item 5 -- no adverse events.**
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- None **Please note: to clarify answer to next item (#20), the answer should be not applicable (N/A) since no adverse events reported.**
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 4,0
- Geschlecht
- U
- Eingang
- 23.04.2022
- Impfdatum
- 15.04.2022
- Beginn
- 15.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No other issues or concerns noted; Varivax had a temperature excursion and had been administered; This spontaneous report was received from an office manager, referring to a 4 year old patient of unknown gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported. On 07-APR-2022, a temperature excursion was of -6.9 Centigrade degrees (?C), during 9 minutes occurred. A previous temperature excursion was not reported. On 15-APR-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) lot# U008180, expiration date reported as 12-DEC-2023, for prophylaxis (strength, dose, route and frequency were not reported). No other issues or concerns noted. This is one of 4 reports received from the same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 2,0
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; Product was administered to patient after temperature excursions; This spontaneous report was received from a medical assistant and refers to a 2-year-old patient of unspecified gender. The patient's pertinent medical history, concomitant medications, past drug reactions or allergies were not reported. On 21-JAN-2022, the patient was vaccinated with a reported once dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (concentration, exact dose, route of administration and anatomical site of application were not reported; lot number U008180 that was verified to be a valid lot number with an expiration date reported and established as 12-MAR-2023) as prophylaxis after temperature excursions (product storage error). The temperature excursions were reported as following: 7.4 degrees Fahrenheit (?F) with a time frame of 25 minutes, 6.4 degrees Fahrenheit (?F) with a time frame of 20 minutes and 5.9 degrees Fahrenheit (?F) with a time frame of 15 minutes. It was stated that the vaccine experienced a previous temperature excursion that were reported as: 31.3 degrees Fahrenheit (?F) with a time frame of 10 hours 28 minutes; a range between 6 degrees Fahrenheit (?F) to 14 degrees Fahrenheit (?F) with no exact temperature provided but with a time frame of 1 hour 15 minutes and then 11 degrees Fahrenheit (?F) with a time frame of 6 minutes. No additional adverse event was reported (no adverse event). This is one of several reports received from the same reporter. This patient was reported as patient number three out of seven.; Sender's Comments: US-009507513-2202USA000100: US-009507513-2202USA000257: US-009507513-2202USA000275: US-009507513-2202USA000290: US-009507513-2202USA000324:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- 28.01.2022
- Beginn
- 28.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; Product was administered to patient after temperature excursions; This spontaneous report was received from a medical assistant, and refers to a 12 month old patient of unspecified gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 28-JAN-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot # U008180, expiration date: 12-MAR-2023, for prophylaxis. On unspecified dates, the doses of varicella virus vaccine live (oka/merck)(VARIVAX)underwent temperature excursions of 7.4 Fahrenheit degrees (?F) for 0 Hours 25 Minutes 0 Seconds; 6.4 ?F for 0 Hours 20 Minutes 0 Seconds; 5.9?F for 0 Hours 15 Minutes 0 Seconds; 31.3 ?F for 10 Hours 28 Minutes 0 Seconds; Between range of 6?F to 14?F; No exact temperature was provided; for 1 Hour 15 Minutes 0 Seconds and 11 ?F for 4 Hours 6 Minutes 0 Seconds. No adverse events were reported. This is one of seven cases received from the same source.; Sender's Comments: US-009507513-2202USA000523: US-009507513-2202USA000416: US-009507513-2202USA000290: US-009507513-2202USA000275: US-009507513-2202USA000257: US-009507513-2202USA000100:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 09.02.2022
- Impfdatum
- 02.02.2022
- Beginn
- 02.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional ae reported; undergone temperature excursion; This spontaneous report was received from a registered nurse referring to a 15 year old female patient. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions, and concomitant medications were not reported. On 02-FEB-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) for prophylaxis (lot# U008180 with an expiration date on 12-MAR-2023)(strength, dose, anatomical location, and route of administration were not reported) that had undergone temperature excursion (product storage error). No additional adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 2,0
- Geschlecht
- U
- Eingang
- 09.02.2022
- Impfdatum
- 12.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 9,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Product was admnistered to patient after temperature excursions; This spontaneous report was received from a medical assistant and refers to a 2 year old patient of unknown gender. The patient's concurrent conditions, pertinent medical history, drug reactions or allergies, and concomitant medications were not reported. On 21-JAN-20221, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) lot number U008180 with expiration date 12-MAR-2023 (dosage [frequency reported as once], route of administration, and anatomical location were not reported) for prophylaxis, which experienced temperature excursions: 7.4?F for 0 hours, 25 minutes and 0 seconds; 6.4?F for 0 hours, 20 minutes and 0 seconds; and 5.9?F for 0 hours, 15 minutes and 0 seconds. In addition, the vaccine had previous temperature excursions: at 31.3?F for 10 hours,28 minutes and 0 seconds; between range of 6?F to 14 ?F (no exact temperature was provided) for 1 hour, 15 minutes and 0 seconds; and 11?F for 4 hours, 6 minutes and 0 seconds. This is one of several reports received from the same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 09.02.2022
- Impfdatum
- 27.01.2022
- Beginn
- 27.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no additional AE reported; product administered to patient after temperature excursions; This spontaneous report was received from a medical assistant referring to a 12 month old patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 27-JAN-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) lot # U008180, expiration date on 12-MAR-2023, once, for prophylaxis (dose, and route were not reported). The vaccine was administered to the patient after temperature excursions as follows:7.4 F degrees for 0 hours 25 minutes 0 seconds, 6.4 F degrees for 0 hours 20 minutes 0 seconds and 5.9 F degrees for 0 hours 15 minutes 0 seconds. There were previous temperature excursions at 31.3 F degrees for 10 hours 28 minutes 0 seconds; between range 6 F degrees to 14 F degrees; no exact temperature was provided; for 1 hour 15 minutes 0 seconds; 11 F degrees for 4 hours 6 minutes 0 seconds.No additional adverse events were reported. No product quality complaint involved. This is the report number five out of seven total.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 24.01.2022
- Impfdatum
- 05.01.2022
- Beginn
- 05.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Contraindicated product administered
Exposure during pregnancy
No adverse event
Symptomtext
no additional information provided/ the pregnant patient did not have a clinical adverse event; a pregnant patient was administered a third dose of VARlVAX on 5 JAN 2022; a pregnant patient was administered a third dose of VARlVAX on 5 JAN 2022; This spontaneous prospective pregnancy report has been received from a physician referring to a 23-year-old female patient. The patient's pertinent medical history was not reported. There were no known drug allergies. Historical vaccine included varicella virus vaccine live (Oka/Merck) (VARIVAX). Concomitant vaccine included flu vaccine. On 05-JAN-2022, the pregnant patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 mL (lot# U008180, expiration date 12-MAR-2023; strength was not reported) and sterile diluent (strength, dose, lot#, and expiration date were not reported) subcutaneously for prophylaxis (exposure during pregnancy, contraindicated product administered). The reporter stated that the patient was in her second trimester but could not provide any further details on pregnancy gestation. The last menstrual period (LMP) and estimated due date (EDD) were not known. It was reported that the patient was required to be vaccinated in order to obtain an immigration medical clearance. The patient had not sought medical attention. No treatment was given. No additional information or adverse event (AE) was reported. The patient did not have a clinical AE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Contraindicated product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 27.11.2021
- Impfdatum
- 17.11.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional reported; administered after temperature excursion; This spontaneous report was received from a nurse prescriber and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the varicella virus vaccine live (oka/merck) (VARIVAX) lot # U008180 experienced the temperature excursion of possibly -11.6 degrees Celsius (C) for unknown time. The reporter was unsure of exact temperature and time. On 17-NOV-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U008180 has been verified to be a valid lot number, expiration date was not reported, but upon internal validation established as 12-MAR-2023 (formulation, concentration, exact dose, dose number, route of administration and anatomical location were not reported) for prophylaxis (product storage error). There were no previous excursions reported. No adverse event was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 17.11.2021
- Impfdatum
- 17.11.2021
- Beginn
- 17.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Vaccine given too early
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -